What is Solid Biosciences Inc.'s investing cash flow?

Solid Biosciences Inc. (SLDB) reported investing cash flow of $44.76M in Q1 2026.

How has Solid Biosciences Inc.'s investing cash flow changed year-over-year?

Solid Biosciences Inc.'s investing cash flow increased by 263.0% year-over-year, from -$27.46M to $44.76M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Solid Biosciences Inc. SLDB Investing Cash Flow

Investing Cash Flow at other companies

Sarepta Therapeutics, Inc.SRPT

-$134.39M+53.8%

BiogenBIIB

-$209.5M-343%

Neurocrine BiosciencesNBIX

-$506.2M-3,665%

InsmedINSM

$265.52M+230%

Dyne Therapeutics, Inc.DYN

-$2.39M-264%

Taysha Gene Therapies, Inc.TSHA

-$3.02M-715%

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$910.66M+135%

Enterprise value$634.23M+223%

P/S112.5×-10.3×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s investing cash flow?: Solid Biosciences Inc. (SLDB) reported investing cash flow of $44.76M in Q1 2026.
How has Solid Biosciences Inc.'s investing cash flow changed year-over-year?: Solid Biosciences Inc.'s investing cash flow increased by 263.0% year-over-year, from -$27.46M to $44.76M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.